Orion Pharma Limited reported earnings results for the second quarter and six months ended December 31, 2021. For the second quarter, the company reported sales was BDT 754.32 million compared to BDT 2,394.72 million a year ago. Net income was BDT 402.31 million compared to BDT 282.9 million a year ago. Basic earnings per share from continuing operations was BDT 1.72 compared to BDT 1.21 a year ago.
For the six months, sales was BDT 1,942.05 million compared to BDT 5,323.72 million a year ago. Net income was BDT 472.6 million compared to BDT 473.99 million a year ago. Basic earnings per share from continuing operations was BDT 2.02 compared to BDT 2.03 a year ago.